Litcius/Paper detail

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

Shankar Siva, Mathias Bressel, Simon Wood, Mark Shaw, Sherene Loi, Shahneen Sandhu, Ben Tran, Arun Azad, Jeremy Lewin, Katharine Cuff, Howard Liu, Daniel Moon, Jeremy Goad, Lih‐Ming Wong, Michael Lim‐Joon, Jennifer Mooi, Sarat Chander, Declan G. Murphy, Nathan Lawrentschuk, David Pryor

2021European Urology149 citationsDOI

Topics & Concepts

MedicineRenal cell carcinomaSABR volatility modelInternal medicinePneumonitisPembrolizumabAdverse effectRadiation therapySurgeryOncologyKidney cancerUrologyCancerLungImmunotherapyFinancial economicsVolatility (finance)EconomicsStochastic volatilityRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Diagnosis and Treatment
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial | Litcius